CAIRO: Domestically-produced Sovaldi drug, a hepatitis C treatment, will be available for patients at a reduced price of 520 EGP ($74,) per bottle instead of 680 EGP, announced the Health Ministry Thursday.
The price of the Hepatitis C cure has been reduced at least three times during the past two months, the ministry statement said. A bottle of Sovaldi is consumed over one month.
Around 9,180 Hepatitis C patients with kidney failure will be treated at six medical centers in Cairo, Delta and Upper Egypt, Youm7 reported the Health Ministry as saying.
The ministry recently increased outlets distributing the local Sovaldi to 51 venues.
Importing U.S.-made Sovaldi, which has been in full swing since 2014, was recently halted, and replaced with locally-manufactured drugs. The government hopes to cure some 500,000 patients during 2016 using domestically produced regimens, after the imported ones proved a breakthrough in treating the virus.
The sought-after treatment for Hepatitis C virus, which records in Egypt one of the highest infections worldwide, has reportedly been meeting demand in markets that it will soon manage to end patient waiting lists, head of the National Committee for Control of Viral Hepatitis (NCCVH) Waheed Dous stated in January.
NCCVH previously announced that around 157,000 patients have been treated using the Egyptian-made Sovaldi during 2015.
The Health Ministry has announced coordination with the state-run Long-Live Egypt fund to supply medical centers with medicines, while the ministry will be responsible for medical supervision and laboratories examination.